Disc Medicine plans to resubmit its blood-disorder drug for FDA approval by year-end after a late-stage trial met all its ...

Beat average interest rates with one of these top high-yield savings accounts ...

Positive APOLLO trial topline results demonstrated statistically significant and clinically meaningful benefit across all study endpointsSuccessfully met co-primary endpoints of reduction in ...

LXD 6.10 LTS is out with new image registries, improved disaster recovery, enhanced clustering, and long-term support through ...

All three fibroblast-treated groups had higher disc heights than vehicle controls, measured by normalized percent disc height index (%DHI). In mixed-model analysis, the improvements were statistically ...

Eric Polet, Director of U.S. Operations at Arcitecta, discusses enterprise data management, rising storage costs, metadata-driven governance, data lifecycle optimization and AI readiness.

Disc Medicine's stock surged 32% premarket ahead of Phase 3 APOLLO trial results for bitopertin, an EPP treatment.

Rimini Street to Report Third Quarter 2026 Financial Results on October 29, 2026 A live webcast of the event will be ...

Rollins (ROL) rated Buy with $57 target: contrarian upside after misses. 75% recurring revenue, secular tailwinds; key risks flagged. Click here to read.

Learn how Dell PowerScale helps enterprises navigate AI storage supply challenges with flexible storage architecture, ...

Simplify Alpha™, a Simplify Group™ company, today announced the next phase of its partnership with ServiceNow, the Super Intelligence Control Tower for business reinvention, to develop payer-specific, ...

FY 2026 was a year of discipline. We managed our inventory and capex very closely while keeping operating costs under control. Customer acquisition and sales volumes were very str ...